Postdoctoral researcher – RNATherapeutic in vivo Efficiency

A new project, ReNAissance led by Bruno Pitard, has been selected by an international jury as a high-risk health research program with the potential to generate strategic conceptual and technological breakthroughs in the coming decades. The goal of ReNAissance is to advance medical research by developing a breakthrough therapeutic approach for treating infectious diseases through in vivo mRNA expression encoding therapeutic antibodies. The Pitard laboratory, in the Immunology and New Concepts in immunotherapy (INCIT) department of Inserm and CNRS (Nantes University, France) is seeking an innovative and highly motivated postdoctoral researcher to design mRNA molecules encoding various antibodies and antibody formats to support the discovery of the next generation of in vivo antibody therapies and improve efficacy in clinically relevant animal models.